News|Articles|July 27, 2015

Drug Compounder Recalls Sterile Products

Moses Lake Professional Pharmacy issues recall due to lack of sterility assurance.

 

On July 24, 2015, Moses Lake Professional Pharmacy (Moses Lake, Washington) announced a voluntary recall of human and veterinary sterile compounded drugs due to a lack of sterility assurance.  Although the company has not yet received any reports of product contamination or adverse events, it is issuing the recall after a recent inspection identified an issue with sterility.

The recalled products were produced from July 21, 2014 through July 21, 2015 and were distributed to patients in Arizona, Idaho, Florida, Oregon, Texas, and Washington. More information on the recalled products can be found on FDA’s website.

Source: FDA


Related to this article

Regulatory Roundup—September 2026
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Pharma Logistician Using IoT Based On Blockchain | Image Credit: ©leowolfert -stock.adobe.com
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.